Between amputation and early death, diabetic foot ulcers carry a heavy clinical toll. In clinical cohorts, 14 to 24% of ulcers end in amputation and 20% of patients die within a year after ulcer onset. At presentation, 25% of people have Wagner grade 3 or higher ulcers and 60% of ulcers are neuropathic, setting up wounds that can progress quickly once infection and biofilm take hold.
Key Takeaways
- Wagner grade 3+ ulcers in 25% at presentation
- Mean DFU size is 2.5 cm² at diagnosis
- 60% of DFUs are neuropathic, 15% ischemic, 25% neuroischemic
- 14-24% of DFUs lead to amputation
- 1-year mortality after DFU is 20%
- Osteomyelitis increases amputation risk 5-fold
- DFU annual cost per patient $9,000-$28,000 US
- Lifetime DFU management costs $60,000 per patient
- US annual DFU cost exceeds $15 billion
- Lifetime risk of diabetic foot ulcer (DFU) in patients with diabetes is 19-34%
- Approximately 15% of all patients with diabetes will experience a DFU during their lifetime
- DFU prevalence among diabetic patients is 6.3%
- Neuropathic DFU accounts for 45% of cases
- Peripheral artery disease (PAD) present in 50% of DFU patients
- Neuropathy increases DFU risk 15-fold
Most diabetic foot ulcers are neuropathic, often infected, and require prompt care to prevent osteomyelitis, amputation, and death.
Related reading
01 · Category
Clinical Characteristics25 stats
01
Wagner grade 3+ ulcers in 25% at presentation
02
Mean DFU size is 2.5 cm² at diagnosis
03
60% of DFUs are neuropathic, 15% ischemic, 25% neuroischemic
04
Infection present in 50-60% of DFUs
05
Mean duration of DFU before treatment is 8 weeks
06
Osteomyelitis in 20% of chronic DFUs
07
Superficial ulcers (grade 1) comprise 40% of cases
08
Heel ulcers account for 20% of DFUs
09
Forefoot location in 85% of DFUs
10
Biofilm detected in 60% of chronic wounds
11
Mean age of DFU patients is 65 years
12
45% of DFUs have exposed tendon/bone
13
MRSA isolated in 25% of infected DFUs
14
Average depth of DFU is 3 mm
15
Plantar ulcers in 65% of cases
16
Pus discharge in 35% at presentation
17
Multibacterial infection in 58% of DFUs
18
Mean ulcer perimeter is 7 cm
19
Neuropathic pain absent in 90% of DFUs
20
Wagner grade 2 most common (45%)
21
Erythema around ulcer in 70%
22
Undermining present in 30% of DFUs
23
Mean PUSH score at baseline is 10
24
Bilateral DFUs in 15% of patients
25
Hyperkeratosis in 50% surrounding skin
Interpretation
Clinical Characteristics Interpretation
Clinically, most diabetic foot ulcers are established and complex with 25% presenting as Wagner grade 3 or higher, a mean size of 2.5 cm², 60% neuropathic and another 25% neuroischemic, while infection appears in 50 to 60% and osteomyelitis is seen in 20% of chronic cases.
02 · Category
Complications And Outcomes22 stats
01
14-24% of DFUs lead to amputation
02
1-year mortality after DFU is 20%
03
Osteomyelitis increases amputation risk 5-fold
04
Sepsis from DFU in 10% of cases
05
5-year mortality post-amputation is 50%
06
Gangrene develops in 25% of untreated DFUs
07
Readmission rate for DFU is 30% within 30 days
08
Charcot neuroarthropathy in 10% of DFU patients
09
Contralateral amputation risk 50% within 3 years
10
Hospital stay averages 21 days for DFU
11
85% of diabetes-related amputations from DFU
12
Wound recurrence 40% at 1 year post-healing
13
Cardiovascular death risk 2.5x higher post-DFU
14
Functional limitation in 70% of DFU survivors
15
30-day amputation mortality 10%
16
Biofilm persistence causes 30% treatment failure
17
Renal failure worsens DFU prognosis (OR 3.2)
18
Pain chronicity in 25% post-DFU
19
Mobility loss leads to 40% nursing home admission
20
Antibiotic resistance in 40% of DFU pathogens
21
3-year amputation-free survival 60%
22
Depression prevalence 30% in DFU patients
Interpretation
Complications And Outcomes Interpretation
For diabetic foot ulcers, the complications are severe and time sensitive, with 14 to 24 percent leading to amputation, 20 percent mortality at 1 year, sepsis occurring in 10 percent, and even after amputation the 5 year mortality reaches 50 percent.
More related reading
04 · Category
Prevalence And Incidence28 stats
01
Lifetime risk of diabetic foot ulcer (DFU) in patients with diabetes is 19-34%
02
Approximately 15% of all patients with diabetes will experience a DFU during their lifetime
03
DFU prevalence among diabetic patients is 6.3%
04
Annual incidence of DFU is 2% among diabetic patients
05
In the US, 82,000 diabetic patients undergo lower extremity amputations annually due to DFU complications
06
Global DFU prevalence is estimated at 6.3% (95% CI 5.4-7.3%)
07
Incidence rate of DFU is 1.9% per year in type 2 diabetes
08
In Europe, DFU prevalence is 5.1-7.8%
09
US Medicare data shows 20% of DFU patients develop new ulcers within 1 year
10
DFU incidence in community-dwelling diabetics is 2.2%
11
Prevalence of active DFU in diabetics is 4.8%
12
In Asia, DFU prevalence is 5.5%
13
25% of diabetics develop DFU lifetime risk
14
DFU hospitalization rate is 23% among diabetics
15
Incidence of DFU recurrence is 40% within 1 year
16
Global DFU cases exceed 1 million annually
17
DFU prevalence in type 1 diabetes is 7.8%
18
In Africa, DFU prevalence is 11.3%
19
US DFU prevalence is 9.9% in high-risk groups
20
DFU affects 6-10% of diabetics at any time
21
Annual DFU incidence in veterans is 4%
22
DFU prevalence in hospitalized diabetics is 12%
23
Lifetime DFU risk in type 2 diabetes is 25%
24
DFU incidence rate is 0.2-11% per year globally
25
In Australia, DFU prevalence is 3.2%
26
DFU affects 20 million people worldwide yearly
27
Prevalence of healed DFU history is 25%
28
DFU incidence in dialysis patients is 50%
Interpretation
Prevalence And Incidence Interpretation
From a prevalence and incidence perspective, diabetic foot ulcers affect about 6.3% of people with diabetes globally, while an annual incidence of 2% means roughly 15% of patients will experience a DFU over their lifetime.
05 · Category
Risk Factors And Etiology24 stats
01
Neuropathic DFU accounts for 45% of cases
02
Peripheral artery disease (PAD) present in 50% of DFU patients
03
Neuropathy increases DFU risk 15-fold
04
Smoking doubles DFU risk
05
Previous DFU increases recurrence risk 4-fold
06
High BMI (>30) raises DFU risk by 2.4 times
07
Poor glycemic control (HbA1c >9%) triples DFU risk
08
Male gender increases DFU risk by 1.5 times
09
Duration of diabetes >10 years raises risk 2.3-fold
10
Charcot foot deformity in 13% of DFU cases
11
Insulin use associated with 2-fold DFU risk
12
Callus formation precedes 30% of DFUs
13
Renal impairment increases DFU risk 3-fold
14
Age >65 years doubles DFU incidence
15
Monofilament insensitivity in 68% of DFU patients
16
Ankle brachial index <0.9 in 47% of DFU cases
17
Visual impairment raises DFU risk 1.8 times
18
Deformity (claw toes) in 35% of high-risk feet
19
Hypertension present in 70% of DFU patients
20
Trauma causes 50% of DFU initiations
21
Poor footwear contributes to 40% of DFUs
22
Retinopathy increases DFU risk 2-fold
23
Low education level correlates with 1.6x DFU risk
24
Alcohol consumption raises DFU odds 1.4 times
Interpretation
Risk Factors And Etiology Interpretation
In the risk factors and etiology of diabetic foot ulcers, neuropathy stands out as the key driver with a 15-fold increased risk, and it is further compounded by high prevalence of peripheral artery disease at 50% and the way smoking doubles risk.
06 · Category
Treatment And Healing25 stats
01
Healing rates for DFU are 24-35% at 12 weeks
02
Offloading with total contact cast heals 70% in 6 weeks
03
Negative pressure wound therapy improves healing by 20%
04
Debridement reduces healing time by 3 days/cm²
05
Bioengineered skin substitutes heal 50% faster
06
Antibiotic therapy resolves infection in 80% of mild cases
07
Hyperbaric oxygen therapy heals 75% of refractory DFUs
08
Revascularization success in 85% of ischemic DFUs
09
Mean healing time is 12 weeks with standard care
10
Remission rate after healing is 44% at 1 year
11
Growth factors (PDGF) increase healing by 15%
12
Felted foam offloading heals 60% in 12 weeks
13
Maggot debridement effective in 68%
14
Stem cell therapy shows 80% closure in trials
15
Compression therapy contraindicated in 30% due to PAD
16
Electrical stimulation accelerates healing by 30%
17
Honey dressings heal 70% of superficial ulcers
18
Surgical offloading (Achilles lengthening) heals 90%
19
Collagen dressings improve closure rates by 20%
20
Multidisciplinary care reduces healing time to 8 weeks
21
Laser therapy heals 65% in 12 weeks
22
Silver dressings reduce infection recurrence by 50%
23
Glycemic control improves healing odds 2-fold
24
Amputation-free survival at 1 year is 75%
25
Recurrence prevention with orthotics reduces risk 50%
Interpretation
Treatment And Healing Interpretation
In the Treatment And Healing category, DFU outcomes improve dramatically with the right interventions, with offloading using a total contact cast achieving 70% healing in 6 weeks and negative pressure wound therapy boosting healing by about 20%, far beyond the baseline 24 to 35% healing at 12 weeks.
report visual · Breakdown
Diabetic foot ulcers: baseline severity & key infection burden
A large share present with high-grade ulcers and common wound complications (including infection and biofilm).
25%
Wagner grade 3+ ulcers in 25% at presentation
75%
Hyperbaric oxygen therapy heals 75% of refractory DFUs
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Catherine Wu. (2026, February 13). Diabetic Foot Ulcer Statistics. Gitnux. https://gitnux.org/diabetic-foot-ulcer-statistics
MLA
Catherine Wu. "Diabetic Foot Ulcer Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/diabetic-foot-ulcer-statistics.
Chicago
Catherine Wu. 2026. "Diabetic Foot Ulcer Statistics." Gitnux. https://gitnux.org/diabetic-foot-ulcer-statistics.
Sources & references
10 datasets cited across this report · attribution is report-level